Flopristin/Linopristin

N/A

Report date: 2022/05/18 16:15:25

Base Information

Drug NameFlopristin/Linopristin
Drug Alias NameFlopristin and LinopristinLinopristin and FlopristinLinopristin/FlopristinNXL103 (linopristin+flopristin)XRP-2868 +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein biosynthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co LtdSanofi
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A